Avalo Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US05338F3064
USD
13.15
8.59 (188.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAvalo Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
188.38%
-0.51%
1W
198.86%
-1.37%
1M
223.89%
0.35%
YTD
76.99%
0.54%
1Y
20.42%
13.99%
3Y
-99.01%
66.39%
5Y
-99.83%
77.77%
10Y
-99.83%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
82.89%
0%
82.89%
6 Months
35.71%
0%
35.71%
1 Year
20.42%
0%
20.42%
2 Years
-98.64%
0%
-98.64%
3 Years
-99.01%
0%
-99.01%
4 Years
-99.87%
0%
-99.87%
5 Years
-99.83%
0%
-99.83%

Avalo Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary